Michael D Kappelman

Summary

Affiliation: University of North Carolina
Country: USA

Publications

  1. ncbi Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, 200 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Dig Dis Sci 58:519-25. 2013
  2. ncbi Association of paediatric inflammatory bowel disease with other immune-mediated diseases
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, 130 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Arch Dis Child 96:1042-6. 2011
  3. ncbi Quality of care for gastrointestinal conditions: a primer for gastroenterologists
    Michael D Kappelman
    Division of Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 106:1182-7. 2011
  4. ncbi Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
    Michael D Kappelman
    Department of Pediatrics, Division of Paediatric Gastroenterology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Gut 60:937-43. 2011
  5. ncbi Risk of diagnosed fractures in children with inflammatory bowel diseases
    Michael D Kappelman
    Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 17:1125-30. 2011
  6. ncbi Short pediatric Crohn's disease activity index for quality improvement and observational research
    Michael D Kappelman
    Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:112-7. 2011
  7. ncbi Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
    Michael D Kappelman
    University of North Carolina Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 17:62-8. 2011
  8. ncbi The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
    Michael D Kappelman
    Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children s Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA
    Clin Gastroenterol Hepatol 5:1424-9. 2007
  9. ncbi Quality of care in inflammatory bowel disease: a review and discussion
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 16:125-33. 2010
  10. ncbi Nutritional concerns in pediatric inflammatory bowel disease patients
    Michael D Kappelman
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    Mol Nutr Food Res 52:867-74. 2008

Detail Information

Publications30

  1. ncbi Recent trends in the prevalence of Crohn's disease and ulcerative colitis in a commercially insured US population
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, 200 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Dig Dis Sci 58:519-25. 2013
    ..The aim of our study was to determine the prevalence of Crohn's disease (CD) and ulcerative colitis (UC) in a commercially insured US population and compare prevalences across sociodemographic characteristics and time...
  2. ncbi Association of paediatric inflammatory bowel disease with other immune-mediated diseases
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, 130 Mason Farm Road, campus box 7229, Chapel Hill, NC 27599, USA
    Arch Dis Child 96:1042-6. 2011
    ..Associations between inflammatory bowel diseases (IBDs) and other immune-mediated diseases have been described in adult populations. Whether such associations exist in childhood-onset disease remains unknown...
  3. ncbi Quality of care for gastrointestinal conditions: a primer for gastroenterologists
    Michael D Kappelman
    Division of Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
    Am J Gastroenterol 106:1182-7. 2011
    ....
  4. ncbi Thromboembolic risk among Danish children and adults with inflammatory bowel diseases: a population-based nationwide study
    Michael D Kappelman
    Department of Pediatrics, Division of Paediatric Gastroenterology, University of North Carolina Chapel Hill, Chapel Hill, NC 27599, USA
    Gut 60:937-43. 2011
    ..Recommendations for venous thromboembolism (VTE) prophylaxis in patients with inflammatory bowel disease (IBD) can be refined by incorporating patient-specific risk factors...
  5. ncbi Risk of diagnosed fractures in children with inflammatory bowel diseases
    Michael D Kappelman
    Department of Pediatrics, Division of Pediatric Gastroenterology, University of North Carolina Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 17:1125-30. 2011
    ..We sought to evaluate fracture risk in children with IBD as compared to unaffected controls and determine whether this risk is affected by geographical region (a proxy for sun/vitamin D exposure) and oral steroid use...
  6. ncbi Short pediatric Crohn's disease activity index for quality improvement and observational research
    Michael D Kappelman
    Department of Pediatrics, University of North Carolina at Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:112-7. 2011
    ....
  7. ncbi Utilization of healthcare resources by U.S. children and adults with inflammatory bowel disease
    Michael D Kappelman
    University of North Carolina Chapel Hill, Chapel Hill, North Carolina
    Inflamm Bowel Dis 17:62-8. 2011
    ..The objectives were to describe the healthcare utilization associated with IBD in an insured U.S. population and to determine how sociodemographic factors impact healthcare utilization in this population...
  8. ncbi The prevalence and geographic distribution of Crohn's disease and ulcerative colitis in the United States
    Michael D Kappelman
    Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children s Hospital Boston and Harvard Medical School, Boston, Massachusetts, USA
    Clin Gastroenterol Hepatol 5:1424-9. 2007
    ..This study sought to determine the prevalence of Crohn's disease (CD) and ulcerative colitis (UC) in a large national sample and to compare the prevalence across geographic regions and other sociodemographic characteristics...
  9. ncbi Quality of care in inflammatory bowel disease: a review and discussion
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 16:125-33. 2010
    ..This article reviews the history, rationale, and methods of quality measurement and improvement and identifies the unique challenges in adapting these general strategies to the care of the inflammatory bowel diseases...
  10. ncbi Nutritional concerns in pediatric inflammatory bowel disease patients
    Michael D Kappelman
    Department of Ambulatory Care and Prevention, Harvard Medical School and Harvard Pilgrim Health Care, Boston, MA, USA
    Mol Nutr Food Res 52:867-74. 2008
    ..This article provides an overview of the epidemiology, pathophysiology, evaluation, and management of selected nutritional complications in pediatric IBD...
  11. ncbi Direct health care costs of Crohn's disease and ulcerative colitis in US children and adults
    Michael D Kappelman
    Division of Pediatric Gastroenterology, Department of Pediatrics, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Gastroenterology 135:1907-13. 2008
    ....
  12. ncbi Increased risk of pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 108:240-8. 2013
    ..Patients with inflammatory bowel disease (IBD) may be at increased risk for infections. We aimed to determine the pneumonia risk in IBD and how specific medications affect this risk...
  13. ncbi Diagnostic ionizing radiation exposure in a population-based sample of children with inflammatory bowel diseases
    Lena Palmer
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, USA
    Am J Gastroenterol 104:2816-23. 2009
    ..In this study, we describe this exposure in a population-based sample of children with IBD and determine the characteristics associated with moderate radiation exposure...
  14. ncbi Risk of melanoma and nonmelanoma skin cancer among patients with inflammatory bowel disease
    Millie D Long
    Department of Medicine, University of North Carolina, Chapel Hill, NC, USA
    Gastroenterology 143:390-399.e1. 2012
    ..Patients with inflammatory bowel disease (IBD) are at risk for certain malignancies. We aimed to determine the risk of melanoma and nonmelanoma skin cancer (NMSC) in patients with IBD and how medications affect these risks...
  15. ncbi Isotretinoin use and the risk of inflammatory bowel disease: a case-control study
    Seth D Crockett
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Am J Gastroenterol 105:1986-93. 2010
    ..Isotretinoin is commonly prescribed for the treatment of severe acne. Although cases of inflammatory bowel disease (IBD) have been reported in isotretinoin users, a causal association remains unproven...
  16. ncbi Prevalence and epidemiology of overweight and obesity in children with inflammatory bowel disease
    Millie D Long
    University of North Carolina at Chapel Hill, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:2162-8. 2011
    ....
  17. ncbi Improved outcomes in a quality improvement collaborative for pediatric inflammatory bowel disease
    Wallace V Crandall
    Division of Pediatric Gastroenterology, Hepatology and Nutrition, Nationwide Children s Hospital, Columbus, OH 43205, USA
    Pediatrics 129:e1030-41. 2012
    ..We sought to improve chronic care delivery and outcomes for children with inflammatory bowel disease by using network-based quality improvement methods...
  18. ncbi Increased risk for non-melanoma skin cancer in patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 8:268-74. 2010
    ..We evaluated the risk of non-melanoma skin cancer (NMSC) in patients with IBD and determined how immunosuppressive and biologic medications affect this risk...
  19. ncbi Development of an internet-based cohort of patients with inflammatory bowel diseases (CCFA Partners): methodology and initial results
    Millie D Long
    University of North Carolina, Department of Medicine, Division of Gastroenterology and Hepatology, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 18:2099-106. 2012
    ..The widespread use of the Internet allows for unique research opportunities. We aimed to develop and follow an Internet-based cohort (e-cohort) of patients with self-reported inflammatory bowel diseases (IBD) over time...
  20. ncbi Statins are associated with reduced use of steroids in inflammatory bowel disease: a retrospective cohort study
    Seth D Crockett
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599, USA
    Inflamm Bowel Dis 18:1048-56. 2012
    ..Statin medications have antiinflammatory effects. We sought to determine whether statin use in persons with inflammatory bowel disease (IBD) was associated with reduced rates of steroid use or other markers of disease activity...
  21. ncbi Nonmelanoma skin cancer in inflammatory bowel disease: a review
    Millie D Long
    Department of Medicine, Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 17:1423-7. 2011
    ..We also offer recommendations for prevention of NMSC in these populations...
  22. ncbi Burden of gastrointestinal disease in the United States: 2012 update
    Anne F Peery
    University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Gastroenterology 143:1179-87.e1-3. 2012
    ..Statistical analyses of the most recent data are necessary to guide GI research, education, and clinical practice. We estimate the burden of GI disease in the United States...
  23. ncbi Role of sex in the treatment and clinical outcomes of pediatric patients with inflammatory bowel disease
    Grace J Lee
    Pediatric Gastroenterology Fellowship Program, Nationwide Children s Hospital, Columbus, OH, USA
    J Pediatr Gastroenterol Nutr 55:701-6. 2012
    ..To examine sex differences in medical therapy and clinical outcomes in pediatric patients with inflammatory bowel disease (IBD)...
  24. ncbi Increased risk of pneumocystis jiroveci pneumonia among patients with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Inflamm Bowel Dis 19:1018-24. 2013
    ..Our aims were (1) to determine the incidence and relative risk of PCP in IBD and (2) to describe medication exposures in patients with IBD with PCP...
  25. ncbi Impact of the 2008-2009 economic recession on screening colonoscopy utilization among the insured
    Spencer D Dorn
    Division of Gastroenterology and Hepatology, University of North Carolina School of Medicine, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 10:278-84. 2012
    ....
  26. ncbi Thiazolidinedione use and ulcerative colitis-related flares: an exploratory analysis of administrative data
    Jennifer L Lund
    Department of Epidemiology, University of North Carolina, Gillings School of Global Public Health, Chapel Hill, North Carolina, USA
    Inflamm Bowel Dis 17:787-94. 2011
    ..We examined the association between thiazolidinedione use and ulcerative colitis (UC)-related flares...
  27. ncbi ImproveCareNow: The development of a pediatric inflammatory bowel disease improvement network
    Wallace Crandall
    Division of Pediatric Gastroenterology, Nationwide Children s Hospital, Columbus, Ohio 43205, USA
    Inflamm Bowel Dis 17:450-7. 2011
    ..There is significant variation in diagnostic testing and treatment for inflammatory bowel disease. Quality improvement science methods can help address unwarranted variations in care and outcomes...
  28. ncbi Suboptimal rates of cervical testing among women with inflammatory bowel disease
    Millie D Long
    Division of Gastroenterology and Hepatology, University of North Carolina Chapel Hill, Chapel Hill, North Carolina 27599 7080, USA
    Clin Gastroenterol Hepatol 7:549-53. 2009
    ..We aimed to determine cervical testing rates among women with IBD, specifically those on immunosuppressant medications, and to identify risk factors associated with low incidence of screening...
  29. ncbi Intercenter variation in initial management of children with Crohn's disease
    Michael D Kappelman
    Center for Inflammatory Bowel Disease, Division of Gastroenterology and Nutrition, Children s Hospital Boston, Massachusetts 02115, USA
    Inflamm Bowel Dis 13:890-5. 2007
    ..We undertook this study to determine the extent of intercenter variation in the initial management of children newly diagnosed with Crohn's disease...
  30. ncbi A causal association between isotretinoin and inflammatory bowel disease has yet to be established
    Seth D Crockett
    Division of Gastroenterology and Hepatology, Department of Medicine, University of North Carolina at Chapel Hill, CB 7080, Chapel Hill, North Carolina 27599, USA
    Am J Gastroenterol 104:2387-93. 2009
    ..Case reports have described a possible association between isotretinoin and inflammatory bowel disease (IBD). We critically appraised the literature on this association to assess whether it supports a causal relationship...